Place of bacteriophages in the therapy of gastrointestinal diseases
https://doi.org/10.21518/2079-701X-2015-14-64-72
Abstract
It is known today that the key role in maintaining human health belongs to intestinal microflora. Intestinal microflora can be subdivided into following groups: obligate flora, facultative (opportunistic) flora, transient flora, and pathogenic flora. A condition in which potentially harmful bacteria dominate the intestinal microflora is called dysbiosis. Almost all diseases of the gastrointestinal tract are accompanied by dysbiotic disorders. For some diseases, specific disorders of the composition of the microbiome have already been identified which could exacerbate and worsen the underlying disease. Pathogenic microorganisms often cause an acute intestinal infection (AII) in the human organism. AII are the most common cause of diarrhea in children. In the recent years, under the conditions of the growing antibiotic resistance, there has been an increase in the interest in bacteriophages.
About the Author
M. L. Babayan
Russian Medical Research University named after N.I. Pirogov
Russian Federation
Russian Federation
References
1. Hviid A, Svanstrom H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut, 2011, 60: 49-54.
2. Saulnier DM, Riehle K, Mistretta T-A, et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology, 2011, 141: 1782-1791.
3. Jeffery IB, O'Toole PW, Ohman L, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut, 2012, 61: 997-1006.
4. Ly NP, Litonjua A, Gold DR, Celedon JC. Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? J Allergy Clin Immunol, 2011, 127: 1087-1094.
5. Abrahamsson TR, Jakobsson HE, Andersson AF, et al. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol, 2012, 129: 434-440.
6. Bisgaard H, Li N, Bonnelykke K, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol, 2011, 128: 646-652.
7. Учайкин В.Ф., Новокшенов А.А., Соколова Н.В. Этиопатогенетическая терапия острых кишечных инфекций у детей на современном этапе. Лечащий врач, 2010, 1: 7-13.
8. World Health Organization. The treatment of diarrhоea: a manual for physicians and other senior health workers - 4th revision. 2005.
9. Guarino A, Albano F, Ashkenasi S, et al. ESPGHAN/ESPID Evidence-based Guidelines for the Management of acute gastroenteritis in children in Europe. J Pediatric Gastroenter Nutr, 2008, 46(2): 81-184.
10. Fonseca BK, Holdgate A, Craig JC. Enteral vs intravenous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials. Arch Pediatr Adolesc Med, 2004, 158(5): 483-90.
11. Guarino A, Albano F, Ashkenazi S, Gendrel D, Hoekstra JH, Shamir R, Szajewska H. European Society for Paediatric Gastroenterology, Hepatology and Nutrition/European Society for Paediatric Infectious Diseases Evidence-based Guidelines for the Management of Acute Gastroenteritis in Children in Europe. J Pediat Gastroenterol Nutr, 2008, 46(2): 81-122.
12. Острые кишечные инфекции у детей. Учебно-методическое пособие под ред. Учайкина В.Ф. М.: ГОУ ВПО РГМУ 2005;116.
13. Мазанкова Л.Н., Ильина Н.О. Современные аспекты диагностики и лечения острых кишечных инфекций у детей. Российский вестник перинатологии и педиатрии, 2007, 2: 4-1.
14. Горелов А.В., Усенко Д.В. Современные принципы антибактериальной терапии кишечных инфекций у детей. Фарматека, 2007, 5: 75-80.
15. Бактериофаги: биология и практическое применение. Под ред. Э. Каттер, А. Судаквелидзе. М.: Научный мир, 2012.
16. Unite for Children [Electronic resource]. Mode acess: http://www.unicef.org/media/files/Final_ Diarrhoea_Report_October_2009_final.pdf.
17. Brussow H, Canchaya C, Hardt WD. Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev, 2004, 68 (3): 560602.
18. Kucharewicz_Krukowska A, Slopek S. Immunogenic effect of bacteriophage patients subjected to phage therapy. Arch Immunol Ther Exp (Warsz), 1987, 35(5): 553-61.
19. Захарова И.Н. Микробиота кишечника ребенка и здоровье. Есть ли связь? Медицинский совет, 2015, 6: 47-50.
20. Бехтерева М.К., Иванова В.В. Место бактериофагов в терапии инфекционных заболеваний желудочно-кишечного тракта. Consilium medicum, 2014, 2: 24-29.
21. Huycke MM, Gaskins HR. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med (Maywood) 2004; 229:586-597. Clin. Environ.
22. Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, Dore J. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl. Environ. Microbiol, 1999, 65 (11): 4799-4807.
23. Egert M, de Graaf AA, Smidt H, de Vos WM, Venema K. Beyond diversity: functional microbiomics of the human colon. Trends Microbiol, 2006, 14: 86-91.
24. Qin J, Li R, Raes J, Arumugam M,et al; A human gut microbial gene catalogue established by metagenomic sequencing. MetaHIT Consortium. Nature, 2010, 4, 464(7285): 59-65.
25. Huse SM, Ye Y, Zhou Y, Fodor A. A core human microbiome as viewed through 16 s rRNA sequence clusters. PLoS One, 2012, 7: 34242.
26. Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature, 2011, 473: 174-180.
27. Булатова Е.М., Богданова Н.М. Кишечная микрофлора - один из факторов формирования здоровья человека. Медицинский совет, 2013, 1: 30-33.
28. Roberfroid M, Gibson GR, Hoyles L, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr, 2010, 104: 1-63.
29. Sellitto M, Bai G, Serena G, et al. Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PloS One, 2012, 7: 33387.
30. Schwiertz A, Jacobi M, Frick J-S, et al. Microbiota in pediatric inflammatory bowel disease. J Pediatr, 2010, 157: 240-244.e1.
31. Swidsinski A, Dorffel Y, Loening-Baucke V, et al. Acute appendicitis is characterized by local invasion with Fusobacterium nucleatum/necrophorum. Gut, 2011, 60: 34-40.
Review
For citations:
Babayan ML. Place of bacteriophages in the therapy of gastrointestinal diseases. Meditsinskiy sovet = Medical Council. 2015;(14):64-72. (In Russ.) https://doi.org/10.21518/2079-701X-2015-14-64-72
Views:
491
Email this article 